- Report
- October 2025
- 50 Pages
Global
From €2343EUR$2,650USD£2,035GBP
Sulfaquinoxaline is a chemical compound used in the production of veterinary drugs. It is an antimicrobial agent used to treat bacterial infections in animals, such as poultry, swine, and cattle. It is also used to treat coccidiosis, a parasitic disease that affects the digestive system of animals. Sulfaquinoxaline is available in both injectable and oral forms, and is often used in combination with other drugs.
The sulfaquinoxaline market is driven by the increasing demand for animal-based proteins, such as poultry and pork, and the rising prevalence of animal diseases. The growing awareness of animal health and the increasing demand for animal-based proteins are expected to drive the market in the coming years. Additionally, the increasing demand for animal-based proteins in developing countries is expected to further fuel the market growth.
Some of the major companies in the sulfaquinoxaline market include Bayer AG, Merck & Co., Inc., Zoetis, Inc., Elanco Animal Health, Inc., and Virbac SA. Show Less Read more